NCT03866213View on ClinicalTrials.gov

Validation of a Jaundice Diagnostic and Monitoring Device for Low-Resource Settings

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

August 1, 2019

Primary Completion Date

August 31, 2024

Study Completion Date

August 31, 2024

Conditions
Hyperbilirubinemia, NeonatalJaundice, Neonatal
Interventions
DIAGNOSTIC_TEST

BiliSpec

BiliSpec will quantitatively measure the bilirubin content of a neonatal blood sample.

Trial Locations (3)

30700

RECRUITING

Kamuzu Central Hospital, Lilongwe

77030

ACTIVE_NOT_RECRUITING

Rice University, Houston

Unknown

RECRUITING

Queen Elizabeth Central Hospital, Blantyre

All Listed Sponsors
collaborator

Kamuzu University of Health Sciences

OTHER

collaborator

Lagos University Teaching Hospital (LUTH)

UNKNOWN

lead

William Marsh Rice University

OTHER